within Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G04C_DrugsUsedInBenignProstaticHypertrophy.G04CB02_Dutasteride;

model Dutasteride
  extends Pharmacolibrary.Drugs.ATC.G.G04CB02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>G04CB02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Dutasteride is a dual 5α-reductase inhibitor used to treat benign prostatic hyperplasia (BPH) in men. By inhibiting the conversion of testosterone to dihydrotestosterone (DHT), it reduces prostate size and improves urinary symptoms. Dutasteride is approved and widely used clinically.</p><h4>Pharmacokinetics</h4><p>PK parameters derived from healthy adult male subjects after repeated oral dosing (0.5 mg daily).</p><h4>References</h4><ol><li><p>Gupta, AK, et al., &amp; Williams, G (2022). Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia. <i>The Journal of dermatological treatment</i> 33(7) 2946–2962. DOI:<a href=\"https://doi.org/10.1080/09546634.2022.2109567\">10.1080/09546634.2022.2109567</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/35920739/\">https://pubmed.ncbi.nlm.nih.gov/35920739</a></p></li><li><p>Gupta, AK, et al., &amp; Shemer, A (2024). Efficacy and safety of low-dose oral minoxidil in the management of androgenetic alopecia. <i>Expert opinion on pharmacotherapy</i> 25(2) 139–147. DOI:<a href=\"https://doi.org/10.1080/14656566.2024.2314087\">10.1080/14656566.2024.2314087</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38315101/\">https://pubmed.ncbi.nlm.nih.gov/38315101</a></p></li><li><p>Gupta, AK, &amp; Talukder, M (2025). Efficacy and safety of dutasteride in the treatment of alopecia: a comprehensive review. <i>Expert opinion on pharmacotherapy</i> 26(4) 367–379. DOI:<a href=\"https://doi.org/10.1080/14656566.2025.2461169\">10.1080/14656566.2025.2461169</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/39880789/\">https://pubmed.ncbi.nlm.nih.gov/39880789</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Dutasteride;
